VIRACEPT — Class III drug recall D-1443-2014
Terminated recall by Pfizer Inc., reported 2014-07-23, distributed nationwide. Labeling: Incorrect or missing lot and or Exp Date: The bottles were labeled with an incorrect expiry date 11/
| Recall number | D-1443-2014 |
|---|---|
| Product type | Drug |
| Classification | Class III |
| Status | Terminated |
| Voluntary or mandated | Voluntary |
| Recalling firm | Pfizer Inc., New York, NY, United States |
| Recall initiated | 2014-07-08 |
| Classified | 2014-07-17 |
| Reported by FDA | 2014-07-23 |
| Terminated | 2015-07-06 |
| Distributed | Nationwide (US) |
| Quantity | 1,200 tablets |
| Reason classes | labeling |
| NDC | 63010-0010, 63010-0010-30, 63010-0027, 63010-0027-70 |
| Lot numbers | 11/16, H45241 |
Product
VIRACEPT (R) (nelfinavir mesylate) Tablets, 625 mg, 120-count bottle, Rx only, Manufactured by: Agouron Pharmaceuticals, Inc. A Pfizer Company, Distributed by: ViV Healthcare Company, Research Triangle Park, NC 27709 NDC 63010-027-70
Reason for recall
Labeling: Incorrect or missing lot and or Exp Date: The bottles were labeled with an incorrect expiry date 11/2016. The correct expiry date is 09/2016.
Machine access
This record, with every extracted code, the verbatim FDA record and provenance, is available from the recall API: GET https://api.data.aroqon.com/v1/recalls/D-1443-2014. Look up any UPC, UDI, NDC or lot with /v1/recalls/lookup?code=…. API docs · free and paid keys.
Source: U.S. Food and Drug Administration enforcement report via openFDA (CC0). Structured by Data Foundry (recall-structuring@2); last changed 2026-09-26. Not affiliated with or endorsed by FDA. Not medical or legal advice.